DHR
DHR
NYSE · Life Sciences Tools & Services

Danaher Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks
$216.61
+0.86 (+0.40%)
As of Feb 12, 6:31 PM ET ·
Analyst Consensus
Strong Buy
31
Analysts
Very High
Coverage
Buy 27 87%
Hold 4 13%
Sell 0 0%
Price Target
Analyst Price Target -27.0% upside
Low Target $107.89
Average Target $158.11
High Target $252.83
Current Price $216.61
Current
$216.61
Target
$158.11
$107.89 $158.11 avg $252.83
Scenario Analysis
Bear Case
$107.89
-50.2%
Low target
Base Case
$158.11
-27.0%
Avg target
Bull Case
$252.83
+16.7%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$242.80
-10.8% from high
52-Week Low
$171.00
+26.7% from low
50-Day SMA
$229.40
-5.6% vs SMA
200-Day SMA
$208.83
+3.7% vs SMA
RSI (14)
32.3
Neutral
Target vs 52W High
$158.11
-34.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 33 82% $369.21 -32.0%
DHR
Danaher Corp
 Strong Buy 31 87% $158.11 -27.0%
A
Agilent Technologies Inc
 Buy 29 72% $64.69 -50.1%
IQV
Iqvia Holdings Inc
 Strong Buy 30 80% $82.96 -55.8%
MTD
Mettler-Toledo International
 Hold 21 43% $170.43 -87.6%
WAT
Waters Corp
 Buy 25 56% $189.60 -50.3%
ILMN
Illumina Inc
 Hold 26 50% $169.36 +41.5%
WST
West Pharmaceutical Services
 Strong Buy 23 78% $136.24 -45.3%